Evaluating contemporary radiotherapy approaches in the primary treatment of cervical cancer

International Journal of Gynecological Cancer

Volumn 20, Issue 6, 2010, Pages 1087-1091

  Samant, Rajiv ^a,b   Kobeleva, Sofya ^b   Choan, E ^a,b   Balaraj, Khalid ^c   Le, Tien ^a,b   Fung Kee Fung, Michael ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Cervical cancer; Chemotherapy; Outcomes; Radiotherapy; Treatment approaches

Indexed keywords

CISPLATIN;

ADULT; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; VAGINA DISEASE; AGED; CANADA; COHORT ANALYSIS; EVALUATION STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PATHOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SURVIVAL; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; ONTARIO; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; KAPLAN-MEIER ESTIMATE;

EID: 77956811136     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181e0ef81     Document Type: Article

References (26)

1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18-29.
2. La Vecchia C, Lucchini F, Negri E, et al. Trends of cancer mortality in Europe, 1995-1989: III, Breast and genital sites. Eur J Cancer. 1992;28A:927-998.
3. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynaecological system: an analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol. 1994;10:31-46.
4. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
5. Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol. 2009;36:155-169.
6. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;20:CD002225.
7. Mangioni C, Landoni F, Colombo A, et al. Concurrent platinum-based chemo- and radiotherapy for locally advanced cervical cancer: a new gold-standard treatment? Ann Oncol. 1999;10:647-648.
8. Thomas GM. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol. 2000;10:44-50.
9. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154-1161.
10. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340:1137-1143.
11. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
12. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatinun-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
13. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339-1348.
14. Yamashita H, Nakagawa K, Tago M, et al. Treatment results and prognostic analysis of radical radiotherapy for locally advanced cancer of the uterine cervix. Br J Radiol. 2005;78:821-826.
15. Garipagaoglu M, Kayikcioglu F, Kose M, et al. Adding concurrent low dose continuous infusion of cisplatin to radiotherapy in locally advanced cervical carcinoma: a prospective randomized pilot study. Br J Radiol. 2004;77:581-587.
16. EC, Dahrouge S, Samant R, et al. Radical radiotherapy for cervix cancer: the effect of waiting time on outcome. Int J Rad Oncol Biol Phys. 2005;61:1071-1077.
17. Spensley S, Hunter RD, Livsey JE, et al. Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clin Oncol. 2009;21:49-55.
18. Loizzi V, Cormio G, Loverro G, et al. Chemoradiation: a new approach for the treatment of cervical cancer. Int Gynecol Cancer. 2003;13:580-586.
19. Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. Clin Oncol. 2007;25:2952-2965.
20. Singh TT, Singh IY, Sharma DT, et al. Role of chemoradiation in advanced cervical cancer. Indian Cancer. 2003;40: 101-107.
21. Vistad I, Cvancarova M, Fossa SD, et al. Post radiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients? Int J Radiat Oncol Biol Phys. 2008; 71:1335-1342.
22. King M, McConkey C, Latief TN, et al. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol. 2006;18:38-45.
23. Kim YS, Shin SS, Nam JH, et al. Prospective randomized comparison of monthly flurouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol. 2008;108:195-200.
24. Mitra D, Ghosh B, Kar A, et al. Role of chemoradiotherapy in advanced carcinoma cervix. Indian Med Assoc. 2006; 104:432, 434, 436.
25. Atahan IL, Onal C, Ozyar E, et al. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int Gynecol Cancer. 2007;17:833-842.
26. Chemoradiotherapy for Cervix Cancer Meta-Analysis Collaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervix cancer: individual patient data meta-analysis. Cochrane Database Syst Rev. 2010;1:CD008285.